Key result
Ticagrelor and clopidogrel outcomes in the PLATO trial were discussed in an editorial highlighting the need to independently verify reports of paradoxical excess mortality.
Key points are not available for this paper at this time.
Design
Editorial
An editorial discussing the viewpoint on paradoxical excess mortality in the PLATO trial comparing ticagrelor and clopidogrel.
No takes yet. Share an insight, caveat, or question.
Ohman et al. (2011) studied this question. Ticagrelor and clopidogrel outcomes in the PLATO trial were discussed in an editorial highlighting the need to independently verify reports of paradoxical excess mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: